Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Clinical trial NCT00707967 · COMPLETED
Trial details
- NCT number
- NCT00707967
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-30
- Primary completion
- 2009-05-27
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.